Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 3.3 | 2.4 | 3.6 | 2.6 |
| Revenue growth | 37.2% | -31.9% | 36.2% | |
| Cost of goods sold | 2.7 | 2.4 | 1.9 | 1.1 |
| Gross profit | 0.7 | 0.0 | 1.7 | 1.5 |
| Gross margin | 19.6% | 1.3% | 47.2% | 56.5% |
| Sales and marketing | 1.7 | 1.8 | 1.4 | 0.8 |
| Research and development | 1.5 | 3.8 | 1.5 | |
| General and administrative | 2.3 | 4.0 | 5.4 | 3.8 |
| EBIT | -4.9 | -9.6 | -6.6 | -3.6 |
| EBIT margin | -145.2% | -395.0% | -183.6% | -135.4% |
| Pre-tax income | 5.5 | 9.8 | 9.1 | -4.3 |
| Income taxes | 11.0 | 19.6 | 0.0 | 0.0 |
| Tax rate | 200.0% | 200.0% | 0.0% | 0.0% |
| Net income | -5.5 | -9.8 | -16.0 | -4.3 |
| Net margin | -164.0% | -403.4% | -446.2% | -163.8% |
| |
| Diluted EPS | ($0.65) | ($1.23) | ($7.37) | ($3.22) |
| Shares outstanding (diluted) | 8.4 | 8.0 | 2.2 | 1.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|